Insider trades

Josef H. Von Rickenbach, Director of Rein Therapeutics RNTX, has filed 4 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $49.7K. The latest trade was on 05/27.

Josef H. Von Rickenbach

Director
First filing
24/03/01
Trades
9 trades
Buys / sales
4 / 0
12-month net buying
$49.7K
Last trade
05/27

Trading activity

Transactions

Trade type
RNTX
Open-market buy05/21–05/2705/2847,060 sh4 trades$1.06avg.$49,700.7+304.5%